Form 4: Health Catalyst COO Sells Shares to Cover Tax Obligations Following RSU Vesting

Health Catalyst's Chief Operating Officer, Daniel LeSueur, sold 3,802 shares of common stock on June 2, 2025, at $3.6348 per share, solely to satisfy tax withholding obligations related to vested restricted stock units.

Summary

• Daniel LeSueur, Chief Operating Officer of Health Catalyst, Inc. (HCAT), reported a transaction on June 2, 2025.
• The transaction involved the disposition of 3,802 shares of Health Catalyst Common Stock.
• The shares were sold at a price of $3.6348 per share.
• This sale was classified as an 'F' transaction code, indicating it was a 'sell to cover' transaction.
• The purpose of the sale was to cover tax withholding obligations in connection with the vesting of the Issuer's Restricted Stock Units (RSUs).
• The sale was mandated by Health Catalyst's equity incentive plans, requiring tax withholding obligations to be funded by a 'sell to cover' transaction, and was not a discretionary trade by Mr. LeSueur.
• Following this transaction, Daniel LeSueur beneficially owns 202,030 shares of Health Catalyst Common Stock directly.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as the transaction indicates RSU vesting, which is a positive compensation event for the executive. The sale itself is neutral as it's non-discretionary and for tax purposes, not a reflection of insider sentiment about the company's prospects.

Positives

• The transaction indicates the vesting of Restricted Stock Units (RSUs) for the Chief Operating Officer, which is a positive event for the executive and reflects compensation earned.
• The sale was non-discretionary and solely for tax withholding purposes, suggesting it does not reflect a lack of confidence in the company by the insider.

Negatives

• The transaction resulted in a reduction of 3,802 shares from the Chief Operating Officer's direct beneficial ownership.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The sale represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units.
• This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

This is a routine insider transaction (Form 4) related to executive compensation and tax obligations, common across publicly traded companies where equity awards are part of compensation packages. It does not provide specific insights into broader industry trends or competitive positioning beyond the company's standard compensation practices.

Related Party Transactions

• The transaction involves the sale of shares by a Chief Operating Officer to cover tax obligations related to equity awards granted by the company, which is a standard related-party compensation event.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes, not indicative of a change in management's confidence.
• Employees: Reflects standard equity compensation practices within the company.

Key Dates

Keywords

Health Catalyst, HCAT, Form 4, Insider Transaction, Stock Sale, Restricted Stock Units, RSU Vesting, Tax Withholding, Chief Operating Officer